{"id":"W2735850899","doi":"10.1111/bjh.14829","title":"Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from <scp>ENEST</scp>xtnd","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Adverse effect; Rash; Internal medicine; Clinical endpoint; Nausea; Clinical trial; Oncology; Myeloid leukemia; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007758042,0.0003944162,0.001630795,0.0004606933,0.0002157385,0.0001508359,0.000655604,0.000500904,0.0001870657],"category_scores_gemma":[0.00378761,0.0004477825,0.0002468551,0.0002341723,0.0003479986,0.0005821934,0.0001562617,0.001206901,0.00005059457],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00387327,"about_ca_system_score_gemma":0.003750221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004025174,"about_ca_topic_score_gemma":0.009828035,"domain_scores_codex":[0.9957653,0.0002794038,0.001946456,0.0006221975,0.0005268637,0.0008597723],"domain_scores_gemma":[0.9961553,0.0007982704,0.001747626,0.0007447267,0.000234176,0.000319856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"observational","study_design_scores_codex":[0.002952652,0.003726866,0.05773425,0.0006452336,0.0008750662,0.7187152,0.001476202,0.02788127,0.004202918,0.00009914702,0.0218856,0.1598056],"study_design_scores_gemma":[0.3479252,0.004734063,0.3900183,0.0127175,0.0006472872,0.2081786,0.0003612739,0.01962919,0.005452146,0.0005675941,0.009139381,0.0006294841],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832616,0.01336339,0.0002763187,0.0007555654,0.0006670262,0.000616385,0.0000971624,0.00003039146,0.0009321892],"genre_scores_gemma":[0.9888579,0.007086261,0.002498308,0.0001307092,0.000773505,0.00002998805,0.0002109968,0.00007369236,0.0003386828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5105366,"threshold_uncertainty_score":0.9999507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02974140965789916,"score_gpt":0.3104479218850639,"score_spread":0.2807065122271647,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}